๐Ÿ‡ณ๐Ÿ‡ฟ Country Profile

New Zealand

Medicine from India reaching New Zealand

๐Ÿ‡ณ๐Ÿ‡ฟ $83.9M
Dual-source profile. Both series show finished pharmaceutical products aligned to calendar year (Janโ€“Dec). Stats NZ records what New Zealand imports from India. DGCIS records what India exports to New Zealand. Category and product detail from DGCIS.
$83.9M
Scale
New Zealand's patients receive $83.9M in Indian pharmaceutical products annually, almost entirely finished medicines ready for dispensing.
91%
Medicine
Overwhelmingly finished medicines, drug formulations account for 91% of shipments.
1.6ร—
Trajectory
New Zealand's imports of Indian pharmaceutical products have grown 1.6ร— over the past decade, from $50.9M in 2014 to $83.9M in 2025.
Context
Part of India's pharmaceutical supply network across Asia-Pacific.
โœฆ
Impact
Indian pharmaceutical companies have both exported to and invested directly in New Zealand, building trade and operational presence.
Export Trend Stats NZ CY DGCIS India-reported
Beyond Finished Medicines DGCIS CY 2014–2025

Additional pharmaceutical categories from DGCIS, APIs, surgical, herbal, and more

Category Mix, FY 2025–26 DGCIS
Medicines $57.6M (90.9%) Surgical & Hospital Supplies $2.2M (3.5%) Medicine Ingredients $2.0M (3.2%) Traditional & Herbal $1.3M (2.0%) Vaccines $0.19M (0.3%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in New Zealand Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into New Zealand: $3.0M across 25 filings (2011-2016).